Leading CDMO to attend CPHI Milan 2026 in Italy
Globally renowned contract development and manufacturing organisation (CDMO) Piramal Pharma Solutions (PPS) will showcase its expertise at the upcoming CPHI…
Globally renowned contract development and manufacturing organisation (CDMO) Piramal Pharma Solutions (PPS) will showcase its expertise at the upcoming CPHI…
Few areas of pharmaceutical manufacturing have attracted as much investment in recent years as high-potency containment. The expansion of oncology…
In an attempt to meet regulatory expectations, clinical trials are challenged by highly complex protocol design. But these study plans…
Upscaling the complex processes for bioconjugates manufacturing is now a necessity in the pharma industry as demand surges for innovative…
Artificial intelligence (AI) is becoming widely adopted in clinical data management, but the most persuasive use cases are rarely the…
For years, biopharma has accumulated vast volumes of data. Now, as the industry races toward an AI-driven future, that data…
Post-marketing approval studies in clinical research for cancer typically suffer from poor engagement and protracted timelines – driving up costs…
The pharmaceutical industry is investing heavily in therapies capable of delivering high-potent treatments to diseased cells while limiting damage to…
Traditional approaches to patient-trial matching often rely solely on structured data, leading to inaccurate eligibility lists and missed opportunities to…
This is the first episode in our second season exploring the evolving landscape of real-world data and its role in…